Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
My Watchlist
Top Indices
My Portfolio

Alpine Immune Sciences Inc (NQ: ALPN )

N/A UNCHANGED
Last Price Updated: 4:00 PM EDT, May 17, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Alpine Immune Sciences Inc

< Previous 1 2 3 4 5 6 7 Next >
Wall Street Braces For Another Red Day Ahead Of More Inflation Data While Bitcoin Holds Above $70K: Analyst Sees Any Pullback As 'Phenomenal Buying Opportunity'
The negative mood on Wall Street may persist as investors await the release of another inflation report, which will have significant implications for the near-term trend in cons 
Via Benzinga
Topics Economy
Exposures Interest Rates
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday
We're starting off Thursday with a breakdown of all the biggest pre-market stock movers traders will want to keep an eye on this morning! 
Via InvestorPlace
Why Rallybio Shares Are Trading Higher By Around 78%; Here Are 20 Stocks Moving Premarket
Shares of Rallybio Corporation (NASDAQ: RLYB) rose sharply in today’s pre-market trading after the company announced a collaboration with Johnson & Johnson to advance therapeutics for pregnant... 
Via Benzinga
Navigating 8 Analyst Ratings For Alpine Immune Sciences
Via Benzinga
Alpine Immune Sciences Inc. (NASDAQ: ALPN) is a Stock Spotlight on 3/19
Via Investor Brand Network
Evaluating Alpine Immune Sciences: Insights From 6 Financial Analysts
Via Benzinga
Why Bitcoin-Linked MicroStrategy Along With Adial Pharmaceuticals, Alpine Immune Sciences, Marin Software, And Tesla Are On Investors' Radars Today
On Wednesday, key U.S. stock indexes closed lower, as the Dow Jones Industrial Average fell by 1.1% to 38,461.51, the S&P 500 dropped nearly 1% to 5,160.64, and the Nasdaq ended the day down by 0.8% at... 
Via Benzinga
Topics Stocks
Exposures US Equities
ALPN Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of Alpine Immune Sciences, Inc. Is Fair to Shareholders
From Halper Sadeh LLC
Via Business Wire
Vertex Pharmaceuticals Nabs Alpine Immune Sciences In $4.9 Billion Deal
The companies expect the deal to close later this quarter. 
Via Investor's Business Daily
Alpine Immune Sciences Shares Updated Clinical Data from Povetacicept in IgA Nephropathy
From Alpine Immune Sciences, Inc.
Via Business Wire
Recap: Alpine Immune Sciences Q4 Earnings
Via Benzinga
Preview: Alpine Immune Sciences's Earnings
Via Benzinga
Alpine Immune Sciences Inc. (NASDAQ: ALPN) is a Stock Spotlight on 3/8
Via Investor Brand Network
Vertex Enters Into Agreement to Acquire Alpine Immune Sciences
From Alpine Immune Sciences, Inc.
Via Business Wire
Why Is Kidney Disease-Focused Alpine Immune Sciences Stock Trading Higher On Wednesday?
Alpine Immune Sciences explores strategic options, potentially selling amid interest from buyers. The Seattle-based firm, with soaring stock up over 400%, evaluates various possibilities. 
Via Benzinga
Lamb Weston Reports Weak Earnings, Joins Paragon 28, Resources Connection And Other Big Stocks Moving Lower On Thursday
U.S. stocks were higher, with the Dow Jones gaining over 150 points on Thursday. 
Via Benzinga
Topics Stocks
Exposures US Equities
Alpine Immune Sciences Inc. (NASDAQ: ALPN) is a Stock Spotlight on 2/29
Via Investor Brand Network
In-Depth Examination Of 6 Analyst Recommendations For Alpine Immune Sciences
Via Benzinga
Alpine Immune Sciences to Present Updated Clinical Data for Povetacicept in IgA Nephropathy at the World Congress of Nephrology 2024
From Alpine Immune Sciences, Inc.
Via Business Wire
Alpine Immune Sciences Presents New Translational Data on Povetacicept at the European Lupus Meeting 2024
From Alpine Immune Sciences, Inc.
Via Business Wire
Alpine Immune Sciences to Participate in Upcoming H.C. Wainwright 2nd Annual Autoimmune & Inflammatory Disease Virtual Conference
From Alpine Immune Sciences, Inc.
Via Business Wire
Why Peraso Shares Are Trading Lower By Over 23%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Shares of Peraso Inc. (NASDAQ: PRSO) fell sharply during Tuesday’s session after the company reported worse-than-expected fourth-quarter EPS results. 
Via Benzinga
Alpine Immune Sciences Analysts Boost Their Forecasts After Q4 Earnings
Alpine Immune Sciences, Inc. (NASDAQ: ALPN) reported better-than-expected fourth-quarter financial results. 
Via Benzinga
National CineMedia Reports Upbeat Results, Joins Nordstrom, Core & Main And Other Big Stocks Moving Higher On Tuesday
U.S. stocks were mixed, with the Dow Jones index gaining around 75 points on Tuesday. 
Via Benzinga
Topics Stocks
Exposures US Equities
ALPN Stock Earnings: Alpine Immune Sciences Beats EPS, Beats Revenue for Q4 2023
ALPN stock results show that Alpine Immune Sciences beat analyst estimates for earnings per share and beat on revenue for the fourth quarter of 2023. 
Via InvestorPlace
Alpine Immune Sciences Provides Corporate Update and Full Year 2023 Financial Results
From Alpine Immune Sciences, Inc.
Via Business Wire
Earnings Scheduled For March 18, 2024
Companies Reporting Before The Bell • Niu Techs (NASDAQ:NIU) is expected to report earnings for its fourth quarter. 
Via Benzinga
Alpine Immune Sciences to Report Fourth Quarter and Full Year 2023 Financial Results
From Alpine Immune Sciences, Inc.
Via Business Wire
Alpine Immune Sciences to Participate in Two Upcoming Healthcare Conferences
From Alpine Immune Sciences, Inc.
Via Business Wire
Alpine Immune Sciences to Participate in Two Upcoming Healthcare Conferences
From Alpine Immune Sciences, Inc.
Via Business Wire
< Previous 1 2 3 4 5 6 7 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.